DaRe2Think

BACK TO MAIN INDEX

Patients with atrial fibrillation have a higher risk of stroke, blood clots and memory problems in later life that can lead to dementia.

• The trial is for patients with Atrial Fibrillation who are under 75 years old.
• You maybe required to take blood-thinning tablets that are already widely used and would be part of your future care anyway.
• We are looking to see whether the use of blood thinning tablets reduce the chances of stroke or dementia in later life.
• Follow-up will be automatic with no extra visits for patients, all you need to do is complete some questionnaires every 6 months using your phone, tablet or computer at home.

We don’t currently know whether giving blood thinning medication can reduce this risk if given to patients earlier than they would normally receive it.

This trial will randomly assign patients to either continuing their current care (starting blood thinners when they are older) or given a blood thinning medication at a younger age.

If you participate in this study, you will not need extra visits to the surgery. You will be sent a questionnaire every 6 months to complete on your mobile phone or any internet-connected device. 

The aim of the study is to improve the care of patients with atrial fibrillation and help doctors choose the right medication to prevent long-term complications. 

You can find more detailed information about the study and what taking part involves here.